Activity value 76International Buyer&Supplier,Last transaction date:
2026-04-20Address: 215128 jiangsu,suzhou district 22 tianling road wuzhong economic development
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for suzhou dawnray pharmaceutical co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 6 transactions, with a transaction quantity of 30.9 and a transaction weight of 0.
YearTransactionsQuantityWeight
202514500
2026630.90
Bill of lading data
<
1/15
>
Trade date
2026/04/20
B/L No.
108166416411
Suppliers
suzhou dawnray pharmaceutical co.ltd.
Buyers
công ty cp dược phẩm imexpharm
Product description
Nguyên liệu là dược chất dùng nghiên cứu, kiểm nghiệm: Cefoperazone Sodium and Sulbactam Sodium 2:1 Sterile TC: In -house. Lô: 2512423102. NSX: 12/2025. HD: 12/2027.
Expand
Trade date
2026/04/20
B/L No.
108166416411
Suppliers
suzhou dawnray pharmaceutical co.ltd.
Buyers
công ty cp dược phẩm imexpharm
Product description
Nguyên liệu là dược chất dùng nghiên cứu, kiểm nghiệm: Cefoperazone Sodium and Sulbactam Sodium 1:1 Sterile TC: In -house. Lô: 2601422101. NSX: 01/2026. HD: 01/2028.
Expand
Trade date
2026/02/05
B/L No.
107961048200
Suppliers
suzhou dawnray pharmaceutical co.ltd.
Buyers
công ty cổ phần dược phẩm tenamyd
Product description
АНТИБИОТИКИ, НЕ ДЛЯ ВЕТЕРИНАРИИ, ДЛЯ ФАРМ.ЦЕЛЕЙ, НЕ ЯВЛЯЮТСЯ ОТХОДАМИ ХИМИЧЕСКИХ ВЕЩЕСТВ ИЛИ ОТХОДАМИ ПРОИЗВОДСТВА, ПРИГОТОВЛЕНИЯ И ИСПОЛЬЗОВАНИЯ ФАРМАЦЕВТИЧЕСКОЙ ПРОДУКЦИИ
Expand
suzhou dawnray pharmaceutical co.ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as ceftriaxone sodium,entercavir,neomycin sulphate.
According to the 52wmb.com global trade database, as of 2026-04-20, the company has completed 70 international trades,
with its main trading regions covering pakistan,vietnam,russia etc.
The core products include HS29419000 etc,
often transported via urumchi,port bkk, port abu dhabi etc,
and its main trading partners are biocare pharmaceuticals pvt ltd.,global pharmaceutical corp.s.a.,soneri bank astellas pharma.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on suzhou dawnray pharmaceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.